Recent Courses

Title Credit Start and expiration datessort descending Member price Non-member price
Pathophysiology and Management of Mild to Moderate Pediatric Atopic Dermatitis Journal Supplement
  • 1.00 Contact hours
02/26/2018 to 03/01/2019 $0.00 $0.00
Nurse Practitioners Using Social Media to Advocate for Immunizations
  • 0.50 Contact hours
03/05/2018 to 03/29/2019 $5.00 $10.00
Let It Flow! Voiding Dysfunction and UTIs
  • 1.00 Contact hours
04/17/2017 to 04/30/2019 $10.00 $20.00
Evidence-Based Screening, Assessment for Common Mental Health Disorders
  • 1.25 Contact hours
04/13/2017 to 04/30/2019 $12.00 $25.00
Talking About Sex, Drugs, and Rock and Roll
  • 1.00 Contact hours
04/12/2017 to 04/30/2019 $10.00 $20.00

Pages

Pending Activities

Please login or create an account to view your activities.

Transcript

Please login or create an account to view your activities.

More NAPNAP CE Courses!

PedsCESM News: 

Tackling Atopic Dermatitis: Five Things the Pediatric Care Team Should Know Medscape Education and NAPNAP

This free activity is offered by Medscape and NAPNAP to inform pediatricians, primary care physicians, dermatologists, pediatric nurse practitioners, and physician assistants about the pathophysiology and characteristics of, and treatment options for, mild, moderate, and severe atopic dermatitis (AD) and how to facilitate shared decision making to improve patient adherence and outcomes. (Approved for 0.50 AMA PRA Category 1 credits(s)TM 0.50 ABIM MOC points, 0.50 NAPNAP Contact Hours(s) of which 0.25 contain pharmacology content). This activity is supported by an educational grant from Pfizer Inc. (Expires March 27, 2019)

Clinical Insights in Pediatrics: Type 2 Diabetes in Children and Adolescents with Obesity: Screening, Diagnosis and Management - cmecorner.com

This activity offered by cmecorner.com ​will address T2DM in pediatric patients which is rapidly progressing. The American Diabetes Association has developed criteria for screening diagnosis, and management considerations for T2DM in children and adolescents. (Approved for 0.75 NAPNAP contact hours, of which contain 0.25 pharmacology content) CME: 0.75 AMA PRA Category 1 CreditTM . (Expires April 30, 2019)